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Abstract
Background: Steroidogenesis is a complex, multi-steps biological process in which, cholesterol precursor is
converted to steroids in a tissue specific and tropic hormone dependent manner. Given that steroidogenesis
is achieved by coordinated functioning of multiple tissue specific enzymes, many steroids intermediates/metabolites
are generated during this process. Both the steroid products as well as major lipoprotein cholesterol donor, high-
density lipoprotein 3 (hHDL3) have the potential to negatively regulate steroidogenesis via increased oxidative stress/
reactive oxygen species (ROS) generation.
Methods: In the current study, we examined the effects of treatment of a mouse model of steroidogenesis, Y1-BS1
adrenocortical tumor cells with pregnenolone, 22(R)-Hydroxycholesterol [22(R)-diol] or hHDL3 on ROS production,
phosphorylation status of p38 MAPK and cAMP response element-binding protein (CREB), CREB transcriptional activity
and mRNA expression of StAR, CPY11A1/P450scc and antioxidant enzymes, superoxide dismutases [Cu,ZnSOD (SOD1),
MnSOD (SOD2)], catalase (CAT) and glutathione peroxidase 1 (GPX1). We also detected the steroid product in p38
MAPK inhibitor treated Y1 cells by HPLC-MS / MS.
Results: Treatment of Y1 cells with H2O2 greatly enhanced the phosphorylation of both p38 MAPK and CREB protein.
Likewise, treatment of cells with pregnenolone, 22(R) diol or hHDL3 increased ROS production measured with the
oxidation-sensitive fluorescent probe 2′,7′-Dichlorofluorescin diacetate (DCFH-DA). Under identical experimental
conditions, treatment of cells with these agents also increased the phosphorylation of p38 MAPK and CREB. This
increased CREB phosphorylation however, was associated with its decreased transcriptional activity. The stimulatory
effects of pregnenolone, 22(R)-diol and hHDL3 on CREB phosphorylation was abolished by a specific p38 MAPK
inhibitor, SB203580. Pregnenolone, and 22(R) diol but not hHDL3 upregulated the mRNA expression of SOD1, SOD2
and GPX1, while down-regulated the mRNA levels of StAR and CYP11A1. The p38 inhibitor SB203580 could increase
the steroid production in HDL3, 22(R)-diol or pregnenolone treated cells.
Conclusion: Our data demonstrate induction of a ROS/p38 MAPK -mediated feedback inhibitory pathway by oxy-
cholesterol and steroid intermediates and products attenuates steroidogenesis via inhibition of CREB transcriptional
activity.
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Background
Steroidogenesis is a multi-step process by which the
cholesterol is converted to parent steroid, pregnenolone,
which is further metabolized into other steroids in a tis-
sue specific manner [1, 2]. The cholesterol required for
steroid hormone synthesis can be theoretically obtained
from several different potential sources including de
novo synthesis from acetate, cholesteryl esters stored in
the form of lipid droplets or can be obtained from circu-
lating lipoproteins via low-density lipoprotein (LDL)
receptor/endocytic pathway or SR-BI (for high-density
lipoprotein or HDL)/selective uptake pathway [3, 4]. ste-
roidogenic process is subjected to a dual regulation—acute
and chronic regulation [5], although both are under the
control of tissue-specific tropic hormone. Adrenocortico-
tropin hormone (ACTH) increases glucocorticoid (cortisol
in humans and corticosterone in rodents) synthesis in ad-
renal fasciculata cells, ACTH, K+ or angiotensin II (AngII)
control mineralocorticoid (aldosterone) synthesis in
adrenal glomerulosa cells, follicle-stimulating hormone
(FSH) controls the female sex steroid (progesterone and
estrogen) synthesis in ovarian granulosa cells, whereas
luteinizing hormone (LH) regulates progesterone synthesis
in luteinized ovarian granulosa-luteal cells, androgen pro-
duction in ovarian theca-interstitial cells and testosterone
synthesis in testicular Leydig cells [2].
ROS, such as H2O2 and superoxide anion (O2
●–) are
produced by the mitochondrial electron transport chain
as a byproduct of oxidative phosphorylation [6]. In ste-
roidogenic cells, there is a secondary source for ROS
production. During steroidogenesis, ROS is produced by
cytochrome P450 enzymes catalyzing the steroid hydrox-
ylation steps, particularly by CYP11B1 and to a lesser
extent by CYP11A1 [7]. Moreover, tropic hormones,
ACTH and LH not only stimulate steroid synthesis in
steroidogenic cells of their target tissues but also pro-
mote ROS production, which in turn can cause DNA
damage, protein oxidation and membrane lipid peroxi-
dation in steroidogenic cells [8, 9]. We have previously
reported that age-related decline in steroid synthesis is
caused by excessive oxidative damage to cellular machin-
ery involved in steroidogenesis. In addition, we demon-
strated that aging leads to a significant reduction in
enzymatic and non-enzymatic antioxidant systems and
increased membrane lipid peroxidation in steroidogenic
cells of adrenal gland and testis [10].
Extensive evidence now suggests that low (physio-
logical) but not high concentrations of ROS such as
H2O2 contribute to the regulation of multiple cellular
signaling pathways [11–13]. Given this, we considered
the possibility that ROS generated during steroidogene-
sis may have a negative feedback effect on steroid hor-
mone synthesis. Indeed, there is evidence that ROS such
as H2O2 interferes with the normal transport of
mobilized cytoplasmic cholesterol to and within the mito-
chondria for side chain cleavage in steroidogenic cells
[14–16]. Current evidence suggests that one mechanism
by which ROS may influence cellular signaling pathways,
is via increased phosphorylation and activation of oxidant
sensitive p38 MAPKs [17–19]. p38 MAPKs are activated
by a wide variety of cellular stresses, such as cytokines,
ultraviolet irradiation, heat shock, and osmotic shock, and
in turn regulate a number of metabolic processes includ-
ing cell proliferation, differentiation, apoptosis and other
numbers of different biological effects [20–22]. Our own
studies have shown that oxidant mediated activation of
p38 MAPK inhibits steroidogenesis via down-regulation
of StAR gene transcription [22, 23].
Besides oxidants, there is ample evidence to suggest that
tropic hormones (e.g., FSH and ACTH) themselves can
stimulate the phosphorylation and activation of p38
MAPK. The hormonal activation of p38 MAPK, is pre-
sumably required to terminate the hormone-stimulated
acute steroidogenesis. When considered in this context, it
is likely that p38 MAPK serves as a negative regulator of
steroidogenesis via a feedback dependent mechanism. In
the current study, we sought to determine whether the
steroid intermediates or precursors can stimulate p38
MAPK phosphorylation/activation. We provide evidence
that the steroid substrate/precursors and intermediates,
HDL3, 22(R)-diol and pregnenolone, can promote the
phosphorylation and activation of p38 MAPK. In addition,
phosphorylation and activity of CREB protein, a key tran-
scription factor involved in the transcriptional regulation
of steroidogenic enzymes, is also regulated by these me-
tabolites. The mRNA expression of StAR and CYP11A1
(P450scc), which mediate the first steps in steroidogenesis,
were detected and regulated by these steroid precursors
and intermediates. Finally, we demonstrate that expression
of antioxidant enzymes, SODs and GPX is also subjected
to regulation by the steroid substrate/precursors and
intermediates. In summary, this study provides first evi-
dence that treatment of a model rodent adrenal cell line
with steroid precursors/ metabolites promote ROS pro-
duction, stimulate (activate) p38 MAPK and CREB phos-
phorylation and changed gene transcription of StAR,
CYP11A1 and three major antioxidant enzymes. The
ROS/p38 MAPK-mediated increased phosphorylation of
CREB, however, is associated with a reduction in its tran-
scriptional activity. This attenuation in CREB transcrip-
tional activity in turn results in inhibition of mRNA
expression of key steroidogenic enzymes/proteins such as
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were obtained from Sigma–Aldrich (St. Louis, MO).
Promega Dual-Luciferase Reporter Kit (E1980) was
purchased from Promega Corporation (Madison, WI).
pCRE-Luc cis-reporter plasmid and pLuc-MCS vector
were obtained from Agilent Technologies (Santa Clara,
CA, USA). 20α-hydroxyprogesterone was purchased
from Chemsky International Co., Ltd. (Shanghai, China).
Anti-phospho-CREB (Ser133), anti-CREB, anti-p38
MAPK, and anti-phospho-p38 MAPK (Thr180/
Tyr182) antibodies were supplied by Cell Signaling
Technology, Inc. (Danvers, MA, USA). Anti-GAPDH
was purchased from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). IRDye® 800CW Goat anti-Mouse
IgG (H + L) and IRDye® 800CW Goat anti-rabbit IgG
(H + L) were purchased from LI-COR Biosciences
(Lincoln, NE, USA). SYBR Green Master Mix was
supplied by TAKARA Biotechnology (Dalian) Co.
LTD (Dalian, China). Lipofectamine® 2000 was
obtained from Invitrogen (Life Technologies, Grand
Island, NY, USA). Tissue culture supplies were from
Life Technologies through its Gibco Cell Culture
Media Division (Grand Island, NY, USA).
Cell culture and treatment
SR-BI enriched Y1-BS1 cells were initially kindly supplied
by late Dr David Williams (State University at Stony
Brook, Stony Brook, NY, USA). Y1-BS1 cells, which is
response to hormone and lipoprotein with increased ste-
roidogenesis, is a stable subclone of the Y1 mouse adreno-
cortical tumor cell line isolated by Yasumura et al. 1966
[24, 25]. Y1-BS1 has been proven to be robust in steroido-
genesis and retains responsiveness to hormone [24]. In
contrast to mouse adrenocortical cells/adrenal gland that
produce corticosterone as the major steroid product,
cultured Y1-BS1 cells, both under basal conditions and in
response to trophic hormone stimulation, synthesize and
secrete 20α-hydroxy-Δ4-pregnene-3-one (20α-hydroxy-
progesterone) and 11β,20α-dihydroxy-Δ4-pregnene-3-one
(11β, 20α-hydroxyprogesterone) [26]. Y1-BS1 cells also
secrete small quantities of progesterone. Y1-BS1 cells were
cultured in F-12K medium supplemented with 10%
fetal bovine serum (FBS), and 100 unit/ml penicillin
and 100 μg/ml streptomycin. Cell cultures were main-
tained at 37 °C in a humidified incubator in the pres-
ence of 5% CO2/95% air. When required, cells were
incubated with H2O2 (100 nM) or Bt2cAMP
(2.5 mM) for an appropriate time [27]. For other
treatment, cells were plated and cultured in 6-well or
12-well plates with 10% bovine (b) lipoprotein-
deficient serum (LPDS), and subsequently treated with
human (h) apoE-free high density lipoproteins
(hHDL3, 30 μg/ml), 22(R)-diol (10 μM) or pregneno-
lone (10 μM) for varying incubation time. hHDL3 and
bLPDS were isolated as previously described [28, 29].
Measurement of intracellular reactive oxygen species
(ROS) production
The levels of intracellular ROS were quantified using the
Reactive Oxygen Species Assay Kit purchased from
Beyotime Biotechnology (Shanghai, China). In brief, trip-
licate dishes of cultured Y1-BS1 cells (5X105) cells/well
were pre-loaded with 10 μM DCFH-DA (2,7-Dichlorodi
-hydrofluorescein diacetate) for 30 min. Subsequently,
dishes were washed and incubated with HDL3 (30 μg
protein/ml), 22(R)-diol (10 μM) or pregnenolone
(10 μM) for indicated time. At the end of incubation,
the culture medium was removed from dishes and cells
were immediately lysed and centrifuged. DCFH-DA
fluorescence of the cell lysates was measured using
Tecan Infinite® 200 Pro Microplate Reader with excita-
tion and emission wavelengths of 480 and 525 nm
respectively.
Luciferase assays
Luciferase assays were carried out using cell extracts
from transfected Y1-BS1 cells. Groups of cultured dishes
with 60% confluent Y1-BS1 cells were transfected with
1 μg pCRE- luc plasmid or pLuc-MCS vector per well in
a 24-well plate using Lipofectamine® 2000 as a transfec-
tion reagent (Life Technologies, Grand Island, NY,
USA). Twenty-four hours after transfection, the cells
were re-cultured in F-12K medium supplemented with
10% LPDS overnight followed by treatment with HDL3,
22(R)-diol or pregnenolone for an additional 5 h. Cells
were harvested, lysed and cell extracts luciferase
assayed with dual-luciferase reporter assay system
(Promega) according to the manufacturer’s protocol
and light signal (bioluminescence) was quantified
using a Tecan Infinite® 200 Pro luminometer. Renilla
luciferase was used as a normalization control. The
results are expressed as relative luciferase activity
(ratio of Firefly/Renilla luciferase activity), and data
shown are the mean (±SD) of triplicate values
obtained from a representative experiment that was
independently repeated for at least three times.
RNA isolation and quantitative PCR
Total RNA was extracted from Y1-BS1 cells using a
miRNeasy mini kit (Qiagen Inc., Valencia, CA) following
manufacturer’s instructions. The isolated RNA was tran-
scribed to first strand cDNA at 42 °C for 1 h in an incu-
bation medium containing 2 μg of total RNA and
superscript II reverse transcriptase (Life Technologies,
Grand Island, NY). Amplification of cDNAs was per-
formed with an ABI StepOneplus system according to
manufacturer’s instructions. Each sample contained 2 μl
cDNA (1:10 dilution of the original cDNA), 500 nM
each of sense and antisense primer,10 μl 2x SYBER
Green premix and 0.4 μl Rox (qPCR kit, cat. no.
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RR420A; TAKARA Biotechnology, Dalian, China) in a
final volume of 20 μl. 36B4 was used as an internal con-
trol. All primer sequences used for qPCR are presented
in Table 1.
Western blot analysis
For Western blotting, Y1-BS1 cell lysates were mixed
with equal volumes of 5 × Laemmli sample buffer
[120 mM Tris-HCl, pH 6.8, 2% SDS (w/v), 10% su-
crose (w/v), and 1% 2-mercaptoethanol] and subjected
to 12% SDS-PAGE. For each sample, a constant
amount of protein (10–20 μg) was loaded on the gel.
Protein markers were also loaded on the gel. After
electrophoretic separation, the proteins were trans-
ferred to Immobilon PVDF membranes (Millipore
Corp., Bedford, MA) using standard techniques. The
protein blots were incubated with first antibody for
2 h at room temperature, then probed with IRDye in-
frared secondary mouse or rabbit anti-rabbit IgG and
visualized using the odyssey® infrared imaging system
(LI-COR Biosciences, Lincoln, NE, USA).
Hormone analysis
Y1-BS1 cells were pre-loaded into 12-well plate (5X105
cells/well) and then cultured in F-12K medium supple-
mented with 10% LPDS ± p38 MAPK inhibitor
SB203580 overnight. Subsequently, dishes were washed
and incubated with hHDL3 (30 μg protein/ml), 22(R)-
diol (10 μM) or pregnenolone (10 μM) for 5 h. The
medium samples were collected for hormone analysis
using isotope dilution high performance liquid
chromatography-tandem mass spectrometry (ID-HPLC-
MS / MS). HPLC-MS / MS was performed by Shanghai
Dian Medical Testing Institute (Shanghai, China) as
previously escribed [30].
Statistical analysis
Data are expressed as mean ± SEM for at least three
independent experiments. Statistical analyses were per-
formed using ANOVA followed by the Bonferroni’s post-
test using GraphPad Prism Software, Prism 6 (GraphPad
Software, Inc., San Diego, CA, USA). A statistical differ-
ence of p < 0.05 was considered significant.
Results
H2O2 stimulates the phosphorylation of p38 MAPK and
cAMP responsive CREB transcription factor
Increasing evidence suggests that ROS such as •O2
- , •OH
and H2O2, promote the phosphorylation and activation
of MAPK, among which p38 MAPK is highly responsive
to oxidant stress which has important roles in cell sig-
naling and homeostasis [31–34]. We previously demon-
strated that treatment of Y1-BS1 cells with superoxide,
H2O2 or a lipid peroxidation product, 4-hydroxy-2-
nonenal (HNE) reciprocally inhibited steroid production
and increased the phosphorylation and activation of p38
MAPK [23]. CREB is a key transcription factor that plays
a pivotal role in the regulation of steroidogenic enzymes
at their gene transcription level. It is stimulated by a
number of agents including cAMP, growth factors and
UV exposure [35–37]. The results presented in Fig. 1a
and b demonstrate that treatment of Y1-BS1 cells with
100 nM H2O2 for 5 min caused a robust phosphoryl-
ation of p38 MAPK and a modest but significant stimu-
lation of phosphorylated form of CREB for 20 min,
thereafter the phosphorylation of p38 and CREB de-
creased. Pretreatment of cells with a specific p38
MAPK inhibitor, SB203580 abolished the stimulatory
effects of H2O2 on p38 MAPK and CREB phosphoryl-
ation. These results not only complement the previ-
ously published studies from our laboratory [22] but
also unequivocally establish that CREB is a down-
stream critical target of p38 MAPK in steroidogenic
cells. Meanwhile, we detected that Bt2cAMP could
stimulated both the phosphorylation of p38 MAPK
and CREB (Fig. 1c). While SB203580 abolished the
stimulatory phosphorylation of p38 MAPK by
Bt2cAMP, phosphorylation of CREB was not dimin-
ished (Fig.1d). These results are consistent with the
reported finding that cAMP stimulated the phosphor-
ylation of CREB through PKA pathway [36, 38].
Steroid intermediates, 22(R)-diol and pregnenolone and
circulating cholesterol carrier hHDL3 promote intracellular
ROS production
Steroidogenesis being a multi-step process results in
generation and/or accumulation of a number of inter-
mediary metabolites such as 22(R)-diol and pregneno-
lone, which could potentially further enhance the
intracellular ROS production. This possibility is in line
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with the earlier evidence showing that the steroid inter-
mediates, testosterone, testosterone precursors or ana-
logs e.g., epitestosterone and 17a-methyltestosterone,
can cause oxygen tension sensitive decrement in P450
hydroxylase activity [39]. In addition, the cholesterol
carrier, hHDL3 may also directly or indirectly influence
the ROS production, especially since HDL is known to
participate in cellular signaling [40–42] and is the pre-
dominant form of circulating lipoprotein in rodent and a
major source of cholesterol for steroidogenesis. Here, we
tested the ability of HDL3, 22(R)-diol and pregnenolone
to modulate ROS production in Y1-BS1 cells. For these
studies, Y1-BS1 cells were cultured in regular F-12K
medium containing 10% FBS for a brief period of time
to allow the cells to attach to the plate and then culture
medium was replaced with a fresh medium containing
10% LPDS and dishes incubated overnight. Subse-
quently, the cells were treated ± HDL3, ±22(R)-diol or ±
pregnenolone in the presence of 10% LPDS for various
time points. At the end of incubation, intracellular ROS
generation was evaluated using DCFH-DA assay. The re-
sults depicted in Fig. 2 demonstrate that HDL3, 22(R)-
diol or and pregnenolone, all stimulated ROS generation
with a biphasic response; an initial 10 min rapid re-
sponse and a gradually declining slow phase during the
next 60 min (Fig. 2).
Treatment of Y1-BS1 cells with steroid linked intermediates/
metabolites and hHDL3 results in increased phosphorylation
of p38 MAPK
We next tested the ability of HDL3, 22(R)-diol and preg-
nenolone to promote the phosphorylation of p38 MAPK.
Treatment of Y1-BS1 with hHDL3 (30 μg protein/ml),
22(R)-diol (10 μM) or pregnenolone (10 μM) increased
p38 MAPK phosphorylation in a time dependent man-
ner (Fig. 3a). In each case, the maximum stimulatory
effect of the agent was noted between 20 and 40 min
after exposure and thereafter phosphorylation levels of
p38 MAPK began to decline reaching to the basal levels
at the end of 240 min of incubation. The total p38
MAPK levels, however, were not impacted by treatment
of the cells with any of the three agents (Fig. 3a). We
next evaluated whether hHDL3 and/or steroid metabo-
lites can modulate CREB phosphorylation via p38
MAPK. CREB is one of the best understood phosphoryl-
ation dependent transcription factors [43–45]. It
Fig. 1 H2O2 and Bt2cAMP treatment increases phosphorylation of p38 MAPK and CREB in time course manner. Y1-BS1 cells were pre-treated
without (a, c) or with (b, d) p38 MAPK inhibitor SB203580 overnight and then cultured in medium ± H2O2 (100 nM) or Bt2cAMP (2.5 mM) for
different times. The cell lysates were subjected to SDS–PAGE followed by western blotting analysis. Phospo-specific and total p38 MAPK and
CREB were detected and GAPDH used as loading control. Results are summary of three independent experiments with triplicates in each experiment.
* p < 0.05, ** p < 0.01, *** p < 0.001
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activates transcription of the target genes in response to
a diverse array of stimuli including peptide hormones,
growth factors and neuronal activity. Figure 3b shows
that HDL3, 22(R)-diol or pregnenolone treatment, like
H2O2, increased the phosphorylation of CREB with max-
imal stimulation occurring around 20 min. These results
led us to conclude that HDL3, 22(R)-diol and pregneno-
lone promote CREB phosphorylation via upstream p38
MAPK signaling pathway. To provide additional evi-
dence for this conclusion, we treated cells with these
three agents in the presence and absence of a specific
p38 MAPK inhibitor, SB203580 and reassessed the phos-
phorylation status of both p38 MAPK and CREB pro-
teins. The results presented in Fig. 4 demonstrate that
co-treatment of cells with SB203580 blocked the ability
of HDL3, 22(R)-diol and pregnenolone to stimulate the
phosphorylation of both p38 MAP and CREB, further
confirming the p38 MAPK catalyzed phosphorylation of
CREB.
Steroid intermediates repress CREB activity
The above results indicate that phosphorylated forms of
p38 MAPK and CREB were significantly increased in
Y1-BS1 exposed to HDL3, 22(R)-diol or pregnenolone
compared to vehicle control (Figs. 3 and 4). We next
evaluated the impact of these agents on CREB activity
using a CRE/CREB Reporter kit designed for monitoring
the activity of the cAMP/PKA signaling in cultured cells.
As shown in Fig. 5, CREB activity was slightly but sig-
nificantly decreased in response to treatment with these
three agents for 3 to 5 h. These data open up the
possibility that overproduction/increased accumulation
of steroid intermediates or sustained activation of cells
to HDL leads to enhanced ROS production and conse-
quently loss of CREB activity.
Regulation of StAR and CYP11A1 gene expression
StAR protein mediates rate-limiting step of steroidogen-
esis in which cholesterol was translocated from cyto-
plasm to mitochondria [46]. Then, P450scc (CYP11A1)
catalyzes the conversion of StAR-delivered cholesterol to
pregnenolone [47]. The transcription of both StAR and
CYP11A1 is also regulated by tropic hormones involving
cAMP signaling pathway in multiple transcription fac-
tors, including CREB [48]. Since we observed that CREB
activity is repressed by HDL3, 22(R)-diol and pregneno-
lone, we measured the mRNA levels of its downstream
targets, StAR and CYP11A1 following treatment of cells
with these three agents. As shown in Fig. 6, the mRNA
expression of both StAR and CYP11A1 was down-
regulated by 22(R)-diol and pregnenolone treatment but
not by hHDL3 for 1 or 3 h’ treatment, while the mRNA
expression recovered after a longer time treatment.
Inhibition of p38 MAPK phosphorylation upregulate
steroidogenesis
We have demonstrated that inhibition of p38 MAPK
activity with SB203580 potentiated the Bt2cAMP and
Bt2cAMP + hHDL3-stimulated steroid production in Y1-
BS1 adrenal cells [23]. Although, oxidants-induced acti-
vation p38 MAPK activity critically mediates the oxidant
inhibition of steroid production, we also evaluated the
potential effects of steroid metabolites and intermediates
–induced activation of p38 MAPK on steroid synthesis.
Y1-BS1 cells were treated with three steroid intermedi-
ates in the presence and absence of SB203580 and
medium samples analyzed for steroid production using
HPLC-MS/ MS. As shown in Fig. 7, although additional
substrates (HDL3, 22(R)-diol or pregnenolone) loading
increased the steroid production, inclusion of SB203580
to inhibit the p38 activity could increase the steroid pro-
duction in HDL3, 22(R)-diol or pregnenolone treated
cells. These findings are consistent with previous results
showing that inhibition of p38 MAPK by SB203580
could ameliorate the oxidative stress-induced repression
of steroidogenesis [23].
Upregulation of anti-oxidant enzymes gene expression
ROS-induced oxidative stress is defined as a disturb-
ance in the balance between production of ROS and
antioxidants defenses, particularly the reduced func-
tioning of the antioxidant enzymes (e.g., SOD1 [cyto-
solic CuZn-SOD], SOD2 [mitochondrial Mn-SOD],
GPX1 [cytosolic/mitochondrial glutathione peroxidase 1],
CAT [peroxisomal catalase] and PRDX3 [mitochondrial
Fig. 2 Steroid intermediates stimulate reactive oxygen species (ROS)
production and oxidative stress in Y1-BS1 cells. Y1-BS1 cells were
pre-loaded with 10 μM DCFH-DA for 30 min, washed and incubated
with HDL3 (30 μg/ml), 22(R)-diol (10 μM) or pregnenolone (10 μM)
for different time point. At the end of incubation, the media were re-
moved and cells were immediately lysed and centrifuged. DCFH-DA
fluorescence of the cell lysates was measured using a microplate
reader with excitation and emission wavelengths of 480 and 525 nm
respectively. Results are summary of three independent experiments
with triplicates in each experiment. * p < 0.05, **
p < 0.01, ***p < 0.001
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peroxiredoxin 3] [7, 8, 49–52]. Here we evaluated the
mRNA expression levels of SOD1, SOD2, CAT and GPX1
expression in Y1-BS1 cells following their treatment with
HDL3, 22(R)-diol or pregnenolone. Contrary to our ex-
pectation, we were surprised to see that 22(R)-diol and
pregnenolone but not hHDL3 treatment induced the
mRNA expression of SOD1, SOD2 and GPX (Fig. 8). In
contrast, catalase expression was not affected by any of
these treatments.
Discussion
Steroidogenesis represents a highly complex and multi-
step metabolic process involving the participation of sev-
eral catalytic enzymes, regulatory molecules and cellular
organelles. More specifically, it involves the participation
of various steroidogenic enzymes (e.g., CYP11A1,
CYP11B1, 3βHSD), cholesterol transport proteins (e.g.,
SNAREs, StAR, vimentin), transcription factors (SF-1,
DAX-1, AP-1, CREB and others) and availability of ad-
equate amounts of substrate cholesterol [1, 2, 48, 53, 54].
Although tissue specific tropic hormones are the principal
regulators of steroidogenesis, many growth factors, cyto-
kines and pathophysiological conditions such as oxidative
stress and ER stress also contribute to the regulation of
steroidogenesis [1, 15, 53]. Because steroid synthesis in-
volves many enzymatic steps, a number of intermediate
steroid hormone metabolites are generated and sequen-
tially utilized for the production of tissue specific steroid
hormone. However, for many of these intermediates, con-
version to subsequent metabolite is not efficient resulting
in their increased accumulation in steroidogenic cells and
as such could potentially impact steroidogenesis via
increased ROS formation. Besides, steroidogenesis itself
significantly contributes to the mitochondrial ROS pro-
duction and in turn excessive oxidative stress can impede
steroidogenesis [7, 8, 10, 23, 55]. As noted before, ROS are
derived from molecular oxygen (O2) and comprise mole-
cules with varying oxidant properties. At low concentra-
tions, ROS modulate many cellular processes through
redox-dependent signaling including proliferation, differ-
entiation, apoptosis, immune regulation, cellular adapta-
tion [11–13] and now it is becoming clear that they also
Fig. 3 Steroid intermediates promote phosphorylation of p38 MAPK (a) and CREB (b) in a time dependent manner. Y1-BS1 cells were incubated
with HDL3 (30 μg/ml), 22(R)-diol (10 μM) or pregnenolone (10 μM) for different time point. At the end of incubation, cells were harvested and
lysed for SDS–PAGE followed by western blotting analysis using Phospo-specific and total p38 MAPK and CREB antibodies. Data shown are repre-
sentative of three independent experiments
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participate in the (negative) regulation of steroidogenesis
[7, 8, 10, 23, 55, 56]. In contrast, overproduction or high
levels of ROS results in oxidative stress, a deleterious
process that can be an important mediator of damage to
cellular macromolecular structures including lipids and
membranes, proteins and DNA [57, 58]. Thus, mamma-
lian cells and more specifically, steroidogenic cells possess
a potent anti-oxidant network to scavenge and neutralize
the excessively produced ROS. Under normal physio-
logical conditions, a balance between ROS production
and elimination maintains optimal homeostasis. How-
ever, disturbances of such equilibrium under patho-
physiological conditions can alter the functioning of
normal cellular process with detrimental metabolic
consequences.
In this study we made a novel observation that en-
dogenous steroid intermediates such as 22(R)-diol and
pregnenolone as well as a donor of cholesterol substrate,
hHDL3 can promote ROS production and ensuing
oxidative stress in Y1-BS1 adrenal cells. Our observa-
tions are in line with previous studies showing super
oxide/ H2O2 produced during ACTH-stimulated adrenal
steroid production is involved in the termination of the
steroidogenic response [8]. They demonstrated that
H2O2 produced by P450 enzymes during steroidogenesis
inactivates potent mitochondrial antioxidant enzyme,
peroxiredoxin 3, which in turn triggers a sequence of
events including increased accumulation of H2O2,
activation of p38 MAPK, suppression of StAR mRNA/
protein expression and inhibition of steroidogenesis [8].
Our results suggest that it is not only the H2O2 pro-
duced during Mn-SOD catalyzed dismutation of super-
oxide anions and ensuing inactivation of peroxiredoxin 3
that inhibits steroidogenesis, but also steroid metabolites
such as 22(R)-diol and pregnenolone possess similar
capabilities in promoting ROS production and interfer-
ing with normal steroidogenesis. However, we were
surprised to find that hHDL3 a cholesterol donor for
steroidogenesis also promotes ROS production. This is
even more surprising given that HDL is considered an
antioxidant with relevance to cardiovascular disease [59].
At present we are unable to provide exact explanation
by which HDL treatment of Y1 BS1 cells results in
increased ROS production, but it may be that hHDL3
being a cholesterol donor, delivers excessive amounts of
cholesterol to cells for its catabolism and this leads to
exaggerated production of ROS and excessive oxidative
stress. Obviously, more experimental studies are needed
to sort out among these various possibilities.
Previous data suggest that hydrogen peroxide is a
potent activator for p38 MAPK [23, 60]. Other reports
indicate that tropic hormones such as FSH and ACTH
also induce the phosphorylation and activation of p38
MAPK [8, 61]. Several investigators also reported that
p38 MAPK is one of the regulators of CREB phosphoryl-
ation and its activity [22, 36, 62]. Our data provide
Fig. 4 Inhibition of p38 MAPK blocked the phosphorylation of CREB by steroid intermediates. Y1-BS1 cells were pre-treated without (a) or with
(b) p38 MAPK inhibitor (10 μM) overnight. Cells were then incubated with HDL3 (30 μg/ml), 22(R)-diol (10 μM) or pregnenolone (10 μM) for
20 min. At the end of the incubation, cell lysates were subjected to SDS–PAGE followed by western blotting analysis. Data shown are representative
of three independent experiments
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evidence that HDL3, 22(R)-diol or pregnenolone treat-
ment of Y1-BS1 results in robust phosphorylation of p38
MAPK as a consequence of enhanced ROS production.
Under identical experimental conditions, the phosphor-
ylation of one of the important steroidogenic transcrip-
tion factors, CREB was also induced and based on the
use of inhibitors, the observed phosphorylation of CREB
is mediated by p38 MAPK. This observation is in agree-
ment with previous reports showing that ROS upregu-
lates CREB phosphorylation via p38 MAKP signaling
cascade [22, 63]. Although cAMP-activated PKA and
angiotensin II (AngII) activated protein kinase D (PKD)
catalyzed phosphorylation of CREB at Ser133 is essential
for CREB-induced gene transcription, the p38 MAPK-
dependant phosphorylation of CREB have yielded con-
flicting results [48, 64]. Naqvi et al. reported that PKA
catalyzed CREB phosphorylation and promoted the re-
cruitment of the co-activator proteins CBP (CREB-bind-
ing protein) and p300 to increase the transcription of
CREB-dependent genes in MEF cells, while MSK/MAPK
also phosphorylated CREB without promoting
recruitment of CBP or p300 and could not activated the
transcription of CREB-dependent reporters [38]. A num-
ber of studies have reported that CREB is a target of p38
MAPK and that it phosphorylates and activates the ac-
tivity of CREB [36, 62, 65]. On the contrary, other stud-
ies including our own have shown that p38 MAPK
inhibits the transcriptional (reporter) activity of CREB in
model steroidogenic cell lines, MLTC and Y1, while at
the same time promotes CREB phosphorylation [22, 36,
62]. It is likely that these variable findings about p38
MAPK-mediated phosphorylation and altered CREB ac-
tivity may be due to differences in cell types, metabolic
conditions of the cell under study and functional inter-
action of CREB with specific co-activators/co-suppres-
sors and/or other transcription factors. Our results
provide evidence confirming previous findings from the
laboratory that p38 MAPK inhibits steroidogenesis by
attenuating CREB activity in a classic feedback
mechanism.
Currently, we are exploring the potential mechanism
by which ROS/p38 MAPK inhibition of CREB activity
may lead to impaired steroidogenesis. One possibility we
are considering is the inhibition of StAR gene transcrip-
tion as a result of oxidant-mediated impaired CREB
Fig. 5 Steroid intermediates repress CRE reporter activity in Y1-BS1
cells. Y1-BS1 cells were transfected with Cre-Luc (firefly luciferase) (a)
or pLuc-MCS vector (control) (b) and Renilla luciferase (Rluc, pRL-TK)
for 24 h. Cells were then cultured in F-12K medium supplemented
with 10% LPDS for 10 h before incubating with HDL3 (30 μg/ml),
22(R)-diol (10 μM) or pregnenolone (10 μM) for 1, 3 and 5 h followed
by measurement of firefly and Renilla luciferase activities. Results are
summary of three independent experiments with triplicates in each
experiment. * p < 0.05
Fig. 6 Down-regulation of StAR and CYP11A1 gene expression by
steroid intermediates. Y1-BS1 cells were treated with or without
HDL3 (30 μg/ml), 22(R)-diol (10 μM) or pregnenolone (10 μM) for
different time. Cells were harvested, RNA isolated and reversed
transcribed before subject to qRT-PCR analyses of StAR and
CYP11A1 mRNA levels. 36B4 was used as internal control. Results
are summary of three independent experiments with triplicates
in each experiment. * p < 0.05, ** p < 0.01
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activity. This is in line with the observation that StAR
expression is sensitive to both physiological and patho-
physiological levels of ROS. Moreover, earlier studies
have shown that CREB protein in cooperation with SF1
is a major regulator of StAR protein gene transcription
[66, 67]. Finally, we have earlier shown that oxidants-
p38 MAPK cause inhibition of StAR promoter activity
primarily by interfering with CREB activity [22]. Other
investigators reported that HDL2, very-low-density lipo-
protein (VLDL) and glyco-oxidized VLDL can induce
Cyp11B2 expression and stimulate steroid production in
a human adrenocortical carcinoma cell line, NCI H295R
[68–70]. Saha et al [70] also reported slight increases in
StAR expression by native VLDL and glycol-oxidized
VLDL but not by oxidized VLDL. The data presented
here show that 22(R)-diol and pregnenolone but not
HDL3 repress the gene expression of StAR and
CYP11A1. We further provided the evidence that 22(R)-
diol and pregnenolone-mediated repression of StAR and
CYP11A1 gene expression is achieved through excessive
oxidative stress and associated p38 MAPK signaling cas-
cade. Our steroid hormone production data provide add-
itional support to the notion that SB203580 inhibition of
p38 MAPK augments the steroids production in Y1-BS1
cells treated with steroid metabolites/intermediates. A
number of studies have implicated p38 MAPK signaling
cascade in the regulation of steroidogenesis [71], al-
though p38 MAPK regulation of steroidogenesis is
complex and extent of p38 MAPK varies with steroido-
genic cell types. For example, inhibition of p38 MAPK
activity by SB203580 in IL-1α-stimulated immature rat
Leydig cells leads to downregulation of StAR gene ex-
pression and attenuation of steroid production. [72].
Fig. 8 Up-regulation of anti-oxidant enzymes gene expression by
steroid intermediates. Y1-BS1 cells were treated with or without
HDL3 (30 μg/ml), 22(R)-diol (10 μM) or pregnenolone (10 μM) for
various hours. RNA were isolated and reversed transcribed before
subject to qRT-PCR analyses of SOD1, SOD2, GPX1 and CAT mRNA
levels. 36B4 was used as internal control. Results are summary of
three independent experiments with triplicates in each experiment.
* p < 0.05, ** p < 0.01
Fig. 7 Inhibition of p38 MAPK activity by SB203580 augments
steroid production. Y1-BS1 cells were pre-treated with or without
SB203580 (10 μM) overnight. Cells were then incubated with HDL3
(30 μg/ml), 22(R)-diol (10 μM) or pregnenolone (10 μM) for 5 h.
At the end of the incubation, the medium sampless were
collected for hormone analysis using HPLC-MS / MS. Results are
mean of three independent experiments with triplicates in each
experiment. * p < 0.05, ** p < 0.01
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Other studies have shown that inhibition of p38 MAPK
activity by SB203580 in ovarian granulosa cells is accom-
panied by increased inhibition of LH/hCG/FSH medi-
ated StAR expression and progesterone synthesis [61,
73]. Likewise, in primary cultures of rat adrenal glomer-
ulosa cells, Angiotensin II activates the p38 MAPK and
results in increases in StAR expression and steroid syn-
thesis [71, 74]. Interestingly, our previous studies have
shown that inhibition of p38 MAPK by either SB203580
or SB202190 in adrenocortical from old rats restores
corticosterone synthesis to the levels seen in cells from
young animals [23]. In this study, inhibition of
p38 MAPK activity by SB203580 enhanced 20α-
hydroxyprogesterone production in mouse Y1-BS1 adre-
nocortical tumor cell cotreated with HDL3, 22(R)-diol or
pregnenolone. In addition, we will examine whether
ROS/p38 MAPK modulate the expression of some of
the critical SNARE proteins. In a recent publication, we
identified several SNAREs, whose expression is essential
for cholesterol transport to outer mitochondrial mem-
brane for optimal steroid production [54].
Another surprising finding from our studies was that
treatment of Y1-BS1 with 22(R)-diol and pregnenolone
but not HDL3 leads to increased mRNA expression of
three antioxidant enzymes, SOD1, SOD2 and CAT. In
contrast, studies by Kil et al [8] observed no changes
in the expression of levels of SOD1, SOD2, CAT, and
GPX1 in intact adrenals following treatment of mice
with ACTH. Interestingly, a recently published study
reported that p38 MAPKα causes the induction of
antioxidant enzymes SOD2 and catalase by two dis-
tinct mechanisms [18]. Obviously, more studies are
needed to sort out molecular mechanisms involved in
the transcriptional/posttranscriptional and/or post-
translational regulation of these antioxidant enzymes
in vitro and in vivo.
Conclusion
In conclusion, our studies provide evidence that expos-
ure of adrenal cells to steroid intermediates/metabolites,
22(R)-diol and pregnenolone, and hHDL3 led to
increased ROS production and associated enhanced
phosphorylation of p38 MAPK and CREB. This oxidant-
mediated up-regulation of CREB phosphorylation is
mediated by p38 MAPK. The increased CREB phosphor-
ylation however, was accompanied by a significant loss
of CREB’s transcriptional activity. Furthermore, treat-
ment of cells with 22(R)-diol and pregnenolone and
ensuing oxidative stress resulted in decreased mRNA
levels of StAR and CYP11A1 and increased mRNA levels
of antioxidant enzymes SOD1, SOD2 and CAT. From
these studies we conclude that ROS/p38 MAPK inhib-
ition of CREB transcriptional activity is likely responsible
for ROS-induced feedback inhibition of steroidogenesis.
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